Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer

Bone Marrow Transplantation

Volumn 23, Issue 6, 1999, Pages 621-624

  De Arriba, F ^a   Corral, J ^a   Ayala, F ^a   Heras, I ^a   Moraleda, J M ^a   Osma, M M ^a   Gonzalez Conejero R ^a   Ortuno F ^a   Vicente, V ^a,b  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO MORALES MESEGUER   (Spain)

Author keywords

Autologous transplantation; Breast cancer; GVHD

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; BREAST CANCER; CASE REPORT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; PRIORITY JOURNAL;

EID: 0033055337     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701619     Document Type: Article

References (13)

1. Sullivan KM. Graft-versus-host disease. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1994, pp 339-62.
2. Anderson KC, Weinstein HJ. Transfusion-associated graft-versus-host disease. New Engl J Med 1990; 323: 315-321.
3. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood 1994; 84: 2061-2067.
4. Pati AR, Godder KT, Alohyankar SH et al. Cyclosporin-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma. Bone Marrow Transplant 1996; 17: 1081-1083.
5. Kennedy MJ, Vogelsang GB, Jones RJ et al. Phase I trial of interferon gamma to potentiate cyclosporin-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer. J Clin Oncol 1994; 12: 249-257.
6. Lee CK, Giongrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175-182.
7. Moreb JS, Kubilis PS, Mullins DL et al. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients. Bone Marrow Transplant 1997; 19: 101-106.
8. Esteban JM, Somlo G. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature. Mod Pathol 1995; 8: 59-64.
9. Drobysky W, Thibodeau S, Truitt RL et al. Third-party mediated graft rejection and graft-versus-host disease after T-cell depleted bone marrow transplantation, as demonstrated by hypervariable DNA probes and HLA-DR polymorphism. Blood 1989; 74: 2285-2294.
10. Antman K, Ayash L, Elias A et al. A phase II study of high-dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in woman with measurable advanced breast cancer responding to standard-dose chemotherapy. J Clin Oncol 1992; 10:102-110.
11. Rainey MG, Harrison P, Hows JM et al. Spontaneous graft-versus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myeloid leukemia. Bone Marrow Transplant 1996; 17: 1077-1079.
12. Appleton AL, Swiland L. Pathogenesis of GVHD: role of herpes viruses. Bone Marrow Transplant 1993; 11: 349-355.
13. Ueki A, Yamaguchi M, Ueki H et al. Polyclonal human T-cell activation by silicate in vitro. Immunol 1994; 82: 332-335.